Click here to read the Healio Exclusive, “Interventional glaucoma takes center stage as adoption accelerates.”
Today we have excellent pharmaceutical agents for glaucoma on the market and excellent ways to deploy them.
The buzz around interventional glaucoma should not convey the misleading message that drops are bad and should not be used but rather set us in the direction of employing them mindfully to optimize patients’ lifestyles and control their disease.
A recent survey launched and published by Douglas Rhee and colleagues for the American Society of Cataract and Refractive Surgery found